CVS HEALTH Corp 8-K 2016
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant To Section 13 Or 15(d)
of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): June 14, 2016
CVS HEALTH CORPORATION
(Exact name of registrant as specified in charter)
One CVS Drive,
Woonsocket, Rhode Island 02895
(Address of principal executive offices)
Registrants telephone number, including area code: (401) 765-1500
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Item 8.01. Other Events.
On June 14, 2016, CVS Health Corporation, a Delaware corporation (the Company), issued a press release announcing the expiration and final results of its previously announced cash tender offers that commenced on May 16, 2016. The tender offers expired at 11:59 p.m., New York City time on June 13, 2016.
A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.